Evaluating T1/T2 Relaxometry with OCRA Tabletop MRI System in Fresh Clinical Samples: Preliminary Insights into ZEB1-Associated Tissue Characteristics.

Ahmed Y Sanin, Marcus Prier, Thomas Wartmann, Christian Siba, Katrin Hippe, Maciej Pech, Roland S Croner, Oliver Speck, Ulf D Kahlert, Georg Rose

Journal: Technology in cancer research & treatment 2025;24():15330338251366371

PMID: 40856386

Abstract

IntroductionThe OCRA Tabletop MRI System is a compact, low-field (0.24T) magnetic resonance platform originally developed as an educational device to teach MR physics using chemical test tube-sized samples. Given its capabilities, we explored its diagnostic potential by performing relaxometric analysis on freshly resected human tissue specimens.MethodsMatched pairs of histologically confirmed tumor and non-tumor samples were analyzed with the OCRA MRI system to determine T1 and T2 relaxation times via NMR spectroscopy. In parallel, mRNA expression levels of ZEB1, a key transcription factor involved in WNT signaling, stem cell maintenance and tumor-stroma interactions were quantified for each sample.ResultsThe measured T1 and T2 relaxation times showed distinct profiles between tumor and non-tumor tissues. These biophysical properties were correlated with ZEB1 mRNA expression, revealing preliminary associations between tissue relaxation behavior and molecular signatures relevant to tumor microenvironment dynamics.ConclusionAlthough this pilot study does not yet confirm clinical diagnostic utility, it offers initial biophysical insights into tumor-associated tissue alterations and provides a foundation for future validation studies in larger patient cohorts.

Address: Molecular and Experimental Surgery, Medical Faculty University Hospital Magdeburg, University Clinic for General, Visceral, Vascular and Transplantation Surgery, Otto-von Guericke University, Magdeburg, Germany.; Research Campus STIMULATE, Otto-von Guericke University, Magdeburg, Germany.; Institute of Physics, Otto-von Guericke University, Magdeburg, Germany.; Institute for Pathology, Otto-von Guericke University, Magdeburg, Germany.; Research Campus STIMULATE, Otto-von Guericke University, Magdeburg, Germany.; Department of Radiology and Nuclear Medicine (KRN), Otto-von Guericke University, Magdeburg, Germany.; Molecular and Experimental Surgery, Medical Faculty University Hospital Magdeburg, University Clinic for General, Visceral, Vascular and Transplantation Surgery, Otto-von Guericke University, Magdeburg, Germany.; Research Campus STIMULATE, Otto-von Guericke University, Magdeburg, Germany.; Research Campus STIMULATE, Otto-von Guericke University, Magdeburg, Germany.; Institute of Medical Technology, Otto-von Guericke University, Magdeburg, Germany.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.